| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8240052 | International Journal of Radiation Oncology*Biology*Physics | 2008 | 5 Pages |
Abstract
Cetuximab can be safely administered with chemoradiation for esophageal cancer. Dermatologic toxicity and hypersensitivity reactions were associated with the addition of cetuximab. There was no increase in esophagitis or other radiation-enhanced toxicity.
Keywords
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Howard M.D., Mohan M.D., Thomas M.D., Thomas M.D., L. Austin M.D., Mark M.D., Angela M.D., Devon M.D., Harold M.D., Paul M.D., Jeremy M.D., Nancy R.N., C.C.R.A., Teresa R.N., C.C.R.A.,